The camptothecins

This publication has 62 references indexed in Scilit:

• Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer
  Journal of Clinical Oncology, 2002
• Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules
  Annals of Oncology, 2002
• UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
  The Pharmacogenomics Journal, 2002
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
  The Lancet, 1998
• Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
  The Lancet, 1998
• Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours
  European Journal Of Cancer, 1998
• Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating Factor
  JNCI Journal of the National Cancer Institute, 1993
• Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea.
  Gut, 1992
• Effects of CPT‐11 in combination with other anti‐cancer agents in culture
  International Journal of Cancer, 1992
• Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata^1,2
  Journal of the American Chemical Society, 1966